Dr. Abdulrahman Aloumi is an accomplished pharmaceutical professional and academic researcher with extensive experience spanning clinical, community, and regulatory pharmacy. He holds an MSc in Pharmaceutical Analysis and Quality Control and a PhD in Pharmaceutical Science, both from King’s College London, and has experience teaching at the post-graduate level. In 2021, Dr. Aloumi transitioned into the regulatory sector, and since 2023, he has served as the Head of the Pharmaceutical Pricing Department within the Kuwait Ministry of Health’s Pharmaceuticals and Herbal Medicines Registration and Control Administration.

In this capacity, Dr. Aloumi contributes to national policy-making and strategic regulation. He serves as an active member of several key regulatory bodies, including the Kuwait Pricing Committee, the Gulf Health Council (GHC) Pricing Committee, and the Pharmaceutical Products Classification Committee. Additionally, Dr. Aloumi is dedicated to supporting the institutionalization of Health Technology Assessment (HTA) frameworks, advocating for data-driven, pharmacoeconomic models that comprehensively evaluate the clinical, economic, and social value of innovative medical technologies to balance sustainable healthcare funding with optimal patient access.